These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33889157)

  • 1. GILZ Regulates the Expression of Pro-Inflammatory Cytokines and Protects Against End-Organ Damage in a Model of Lupus.
    Nataraja C; Dankers W; Flynn J; Lee JPW; Zhu W; Vincent FB; Gearing LJ; Ooi J; Pervin M; Cristofaro MA; Sherlock R; Hasnat MA; Harris J; Morand EF; Jones SA
    Front Immunol; 2021; 12():652800. PubMed ID: 33889157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus.
    Jones SA; Toh AE; Odobasic D; Oudin MA; Cheng Q; Lee JP; White SJ; Russ BE; Infantino S; Light A; Tarlinton DM; Harris J; Morand EF
    Ann Rheum Dis; 2016 Apr; 75(4):739-47. PubMed ID: 26612340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?
    Flynn JK; Dankers W; Morand EF
    Front Immunol; 2019; 10():1684. PubMed ID: 31379872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid-induced leucine zipper expression is associated with response to treatment and immunoregulation in systemic lupus erythematosus.
    Mohammadi S; Ebadpour MR; Sedighi S; Saeedi M; Memarian A
    Clin Rheumatol; 2017 Aug; 36(8):1765-1772. PubMed ID: 28601944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Cytokine Autoantibodies in Systemic Lupus Erythematosus.
    Howe HS; Leung BPL
    Cells; 2019 Dec; 9(1):. PubMed ID: 31892200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Human Systemic Lupus Erythematosus Model in Humanised Mice.
    Gunawan M; Her Z; Liu M; Tan SY; Chan XY; Tan WWS; Dharmaraaja S; Fan Y; Ong CB; Loh E; Chang KTE; Tan TC; Chan JKY; Chen Q
    Sci Rep; 2017 Nov; 7(1):16642. PubMed ID: 29192160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dnase1-deficient mice spontaneously develop a systemic lupus erythematosus-like disease.
    Kenny EF; Raupach B; Abu Abed U; Brinkmann V; Zychlinsky A
    Eur J Immunol; 2019 Apr; 49(4):590-599. PubMed ID: 30758851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RORγt expression in T
    Kluger MA; Nosko A; Ramcke T; Goerke B; Meyer MC; Wegscheid C; Luig M; Tiegs G; Stahl RA; Steinmetz OM
    Clin Exp Immunol; 2017 Apr; 188(1):63-78. PubMed ID: 27880975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TLR7 Antibody Protects Against Lupus Nephritis in NZBWF1 Mice by Targeting B Cells and Patrolling Monocytes.
    Murakami Y; Fukui R; Tanaka R; Motoi Y; Kanno A; Sato R; Yamaguchi K; Amano H; Furukawa Y; Suzuki H; Suzuki Y; Tamura N; Yamashita N; Miyake K
    Front Immunol; 2021; 12():777197. PubMed ID: 34868046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxyribonuclease 1-Mediated Clearance of Circulating Chromatin Prevents From Immune Cell Activation and Pro-inflammatory Cytokine Production, a Phenomenon Amplified by Low Trap1 Activity: Consequences for Systemic Lupus Erythematosus.
    Felux J; Erbacher A; Breckler M; Hervé R; Lemeiter D; Mannherz HG; Napirei M; Rammensee HG; Decker P
    Front Immunol; 2021; 12():613597. PubMed ID: 33746957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
    Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
    Front Immunol; 2020; 11():1047. PubMed ID: 32625200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-induced leucine zipper (GILZ) over-expression in T lymphocytes inhibits inflammation and tissue damage in spinal cord injury.
    Esposito E; Bruscoli S; Mazzon E; Paterniti I; Coppo M; Velardi E; Cuzzocrea S; Riccardi C
    Neurotherapeutics; 2012 Jan; 9(1):210-25. PubMed ID: 22125095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GILZ regulates type I interferon release and sequesters STAT1.
    Nataraja C; Flynn J; Dankers W; Northcott M; Zhu W; Sherlock R; Bennett TJ; Russ BE; Miceli I; Pervin M; D'Cruz A; Harris J; Morand EF; Jones SA
    J Autoimmun; 2022 Jul; 131():102858. PubMed ID: 35810690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GILZ regulates Th17 responses and restrains IL-17-mediated skin inflammation.
    Jones SA; Perera DN; Fan H; Russ BE; Harris J; Morand EF
    J Autoimmun; 2015 Jul; 61():73-80. PubMed ID: 26077873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of CD11b Accelerates Lupus Nephritis in Lyn-Deficient Mice Without Disrupting Glomerular Leukocyte Trafficking.
    Gottschalk TA; Hall P; Tsantikos E; L'Estrange-Stranieri E; Hickey MJ; Hibbs ML
    Front Immunol; 2022; 13():875359. PubMed ID: 35634296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of macrophage autophagy ameliorates activated lymphocytes-derived DNA induced murine lupus possibly via inhibition of proinflammatory cytokine production.
    Li B; Yue Y; Dong C; Shi Y; Xiong S
    Clin Exp Rheumatol; 2014; 32(5):705-14. PubMed ID: 25151985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
    Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
    J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity.
    Corradetti C; Jog NR; Cesaroni M; Madaio M; Caricchio R
    J Immunol; 2018 Jan; 200(2):512-522. PubMed ID: 29237779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid-induced leucine zipper (GILZ) controls inflammation and tissue damage after spinal cord injury.
    Mazzon E; Bruscoli S; Galuppo M; Biagioli M; Sorcini D; Bereshchenko O; Fiorucci C; Migliorati G; Bramanti P; Riccardi C
    CNS Neurosci Ther; 2014 Nov; 20(11):973-81. PubMed ID: 25146427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.